跳至主要内容
临床试验/NCT02910960
NCT02910960已完成不适用

Randomized Trial Comparing Two Fine Needle Biopsy Needles for Endoscopic Ultrasound-guided Sampling of Solid Pancreatic Masses.

AdventHealth2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2016年12月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
AdventHealth
入组人数
50
试验地点
2
主要终点
Total area of procured tissue between the two FNB needles

研究概览

简要总结

This is a randomized prospective clinical study comparing the Acquire Biopsy Device to SharkCore Biopsy Device.

详细描述

At EUS, once the pancreatic mass is identified, patients will be randomized to undergo sampling using one of the two FNB needle. All patients will undergo sampling of pancreatic masses using both needles but the needle to be used first will be based on randomization. Subsequent passes will be performed by alternate needles and once onsite diagnosis is established using either needle type, more passes will not be performed for onsite diagnostic adequacy. However, a minimum of at least one pass and a maximum of 8 passes will be performed using both needle types. The number of passes needed to achieve diagnostic adequacy using both needles will documented.

Four dedicated passes will then be performed using the initial randomization sequence for cell block. Two passes will be performed using each needle type and the specimen will be preserved in formalin and sent for cell block processing.

If the doctor cannot obtain enough tissue with the study needles, another needle with a different gauge (19 or 25) will be used. This will also be a maximum of 8 passes. Information about the number of needles used, how many passes were performed, any problems with the needles will be collected. If there is not enough tissue available from these passes to establish a diagnosis, the subject will be asked to come back at another time for a repeat procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled to undergo EUS
  • Patients with solid pancreatic masses on cross-sectional imaging or with jaundice secondary to biliary obstruction
  • Able and willing to provide written or verbal consent

排除标准

  • Unable to safely undergo EUS for any reason
  • Coagulopathy (Prothrombin time > 18 secs, platelet count < 80,000/ml)
  • Active alcohol or other drug use or significant psychiatric illness
  • Pregnancy
  • Unable or unwilling to provide consent

研究组 & 干预措施

Acquire EUS Biopsy Device

Active Comparator

All patients will undergo sampling of pancreatic masses using the Acquire EUS Biopsy Device. Both needles will be used, but the needle to be used first will be based on randomization. A minimum of at least one pass and a maximum of 8 passes will be performed using both needle types.

干预措施: Acquire EUS Biopsy Device (Device)

SharkCore Biopsy System

Active Comparator

All patients will undergo sampling of pancreatic masses using the SharkCore Biopsy System. Both needles will be used, but the needle to be used first will be based on randomization. A minimum of at least one pass and a maximum of 8 passes will be performed using both needle types.

干预措施: SharkCore Biopsy System (Device)

结局指标

主要结局

Total area of procured tissue between the two FNB needles

时间窗: 48 hours

The primary objective of this study is to compare the total area of procured tissue between the two FNB needles in patients undergoing EUS-guided sampling of pancreatic masses. Pancreatic masses sampled using the Acquire Endoscopic Ultrasound Fine Needle Biopsy Device needle should yield a tissue volume greater than the SharkCore Fine Needle Biopsy System needle because the serrated design of the FNB needle tip is expected to procure greater volume of tissue. This will be measured using a specialized digital image analysis software. This hypothesis will be tested by comparing the total tissue volume, tumor volume within the tissue, stroma volume within the tissue, tumor vs. stroma ratio and the macroscopic length of the procured tissue measured in millimeters. When evaluated together, the above measurement provide the total area of tissue procured.

次要结局

  • Diagnostic adequacy between the two FNB needles(48 hours)

研究者

发起方
AdventHealth
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Comparison of Two Fine Needle Biopsy Needles for... | 临床试验